Our findings reveal that DSS mitigates hippocampal neuroinflammation and enhances hippocampal neurogenesis in depression model mice via modulation of the TLR4/NF-κB p65, JAK2/STAT3 and AKT-GSK3β signaling pathways. Here, NFKB1 is linked to depressive symptom measurement.